Schedule 13G ownership disclosure

Haemonetics Corp

Security class unavailable · CUSIP: 405024100

Event date: 2023-12-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
6,523,568
Percent of class
12.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001422848-24-000071
Form type
SC 13G/A
Filer
Capital Research Global Investors
CIK
CIK 1422848
Filed
Feb 09, 2024
Reporting period
Dec 29, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub